A Study to Evaluate the Benefit of Octagam 5%® in Subjects With Pediatric Acute-onset Neuropsychiatric Syndrome (PANS)

PANDAS

PANS – A Detailed Study of the Patients, Their Symptoms, Biomarkers and Treatment Offered in a Scandinavian Cohort Pediatric Acute-Onset Neuropsychiatric Syndrome (PANS): Clinical Characterization and Prospective Course A Study to Evaluate the Benefit of Octagam 5%® in Subjects With Pediatric Acute-onset Neuropsychiatric Syndrome (PANS) Neurobiologic, Immunologic, and Rheumatologic Markers in Youth With PANS Antibiotic Treatment and Intravenous Immunoglobulin Trial for PANDAS Trial of Naproxen Sodium for the Treatment of OCD in Children With PANDAS Antibiotic Treatment Trial for the PANDAS/PANS Phenotype Intravenous Immunoglobulin for PANDAS